Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-06

Clinical Trial Update: Cerebrospinal Fluid Cytology-guided Intrathecal Chemo-holiday Therapy for EGFR-positive NSCLC Leptomeningeal Metastases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at Zhejiang Cancer Hospital evaluates cerebrospinal fluid cytology-guided intrathecal chemotherapy with chemo-holiday therapy for EGFR-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Leptomeningeal Metastases | Phase 2 | Status: NOT_YET_RECRUITING